Weight-Loss Drug Fights Alcoholic Fatty Liver Disease, National Institute on Alcohol Abuse and Alcoholism Study

WEDNESDAY, March 5 (HealthDay News) -- Mice given the weight-loss drug rimonabant became resistant to alcohol’s fat-building effects in the liver, which suggests the medication may help fight alcoholic fatty liver in humans, says a U.S. study.